FIELD: medicine, pharmacy.
SUBSTANCE: invention proposes two variants of composition. By the first variant the composition comprises silver nitrate, hexamethylenetetramine, sodium thiosulfate, alpha-aspartic acid or asparagine, nicotinic acid and water in the amounts given in the invention claim. By the second variant the composition comprises silver nitrate, hexamethylenetetramine or imidazole, imidazole-containing compound of platinum cis-[Pt(NH3)2Im2]Cl2 or cis-[Pt(NH2OH)2Im2]Cl2, alpha-aspartic acid or asparagines, nicotinic acid and water taken in the amount given in the invention claim. Proposed compositions possess the enhanced antitumor activity and simultaneous antibacterial and antiviral effect on body.
EFFECT: improved, enhanced and valuable medicinal properties of pharmaceutical composition.
3 cl, 6 tbl, 3 dwg, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIOXIDANT COMPOSITION (VERSIONS) | 2015 |
|
RU2593587C1 |
| ANTI-LEUCOSIS AND ANTI-MICROBIAL COMPOSITION | 2006 |
|
RU2339376C2 |
| CYTOSTATIC AND ANTIVIRAL COMPOSITION | 1995 |
|
RU2094048C1 |
| ANTITUMOR AND ANTIBACTERIAL COMPOSITION | 1999 |
|
RU2181050C2 |
| DERIVATIVES OF CIS-DIAMMINEDIIMIDAZOLYL PLATINUM DICHLORIDE SHOWING ANTIPROLIFERATIVE ACTIVITY AND A METHOD OF THEIR SYNTHESIS | 1995 |
|
RU2114858C1 |
| BIS-IMIDAZOLE-(1,10)-PHENANTHROLINE COPPER (II) DICHLORIDE SHOWING ANTIBACTERIAL AND ANTIBLASTIC ACTIVITY, METHOD OF ITS SYNTHESIS | 2001 |
|
RU2190616C1 |
| PHARMACEUTICAL COMPOSITION ELICITING ANTITUMOR EFFECT WITH REDUCED ADVERSE EFFECTS AND CONTAINING ANTITUMOR AGENT AND DERIVATIVE OF HYDROXAMIC ACID | 1998 |
|
RU2214238C2 |
| APOPTOSIN AND ANTIOXIDANT COMPOSITION | 2017 |
|
RU2682644C2 |
| METHOD OF OBTAINING CIS-DIAMMINO(1,1-CYCLOBUTANEDICARBOXYLATE)PLATINUM(II) | 2006 |
|
RU2330039C1 |
| AGENT HAVING CYTOSTATIC AND APOPTOSIS-INDUCING ACTIVITY | 2005 |
|
RU2296578C2 |
